PNEUMONIA - BACTERIAL
Clinical trials for PNEUMONIA - BACTERIAL explained in plain language.
Never miss a new study
Get alerted when new PNEUMONIA - BACTERIAL trials appear
Sign up with your email to follow new studies for PNEUMONIA - BACTERIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine aims to shield older adults from pneumonia
⭐️ VACCINE ⭐️ OngoingThis study tests a new vaccine called Pn-MAPS30plus that may protect against more types of pneumonia bacteria than current vaccines. About 127 healthy adults aged 50 to 64 will receive the vaccine or a control to check safety and immune response. The goal is to see if the vaccine…
Matched conditions: PNEUMONIA - BACTERIAL
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:57 UTC
-
New drug aims to speed recovery from severe pneumonia
Disease control OngoingThis study tests whether adding a medicine called CAL02 to standard care helps people with severe bacterial pneumonia recover faster. About 276 hospitalized adults in intensive care will receive either CAL02 or a placebo. The goal is to see if CAL02 shortens the time to clinical …
Matched conditions: PNEUMONIA - BACTERIAL
Phase: PHASE2 • Sponsor: Eagle Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 17, 2026 04:00 UTC
-
New bundle aims to cut risky antibiotic misuse in kids leaving hospital
Knowledge-focused OngoingThis study tests a set of guidelines called a 'discharge stewardship bundle' to help doctors prescribe antibiotics more appropriately for children with pneumonia, urinary tract infections, or skin infections when they leave the hospital. Over 1,100 children and their families fro…
Matched conditions: PNEUMONIA - BACTERIAL
Phase: NA • Sponsor: Children's Hospital of Philadelphia • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC